[
  {
    "ts": "2026-02-19T12:02:12+00:00",
    "headline": "J&J to build $1bn US CGT manufacturing site in Pennsylvania",
    "summary": "The Pennsylvania site is one of four US-based manufacturing sites J&J plans to build over the next four years.",
    "url": "https://www.pharmaceutical-technology.com/news/johnson-johnson-1bn-cell-therapy-manufacturing-site-pennsylvania/",
    "source": "Pharmaceutical Technology",
    "provider": "yfinance",
    "raw": {
      "id": "5ae0c4e5-aa19-3ad7-986f-c6139ce39eab",
      "content": {
        "id": "5ae0c4e5-aa19-3ad7-986f-c6139ce39eab",
        "contentType": "STORY",
        "title": "J&J to build $1bn US CGT manufacturing site in Pennsylvania",
        "description": "",
        "summary": "The Pennsylvania site is one of four US-based manufacturing sites J&J plans to build over the next four years.",
        "pubDate": "2026-02-19T12:02:12Z",
        "displayTime": "2026-02-19T12:02:12Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/pharmaceutical_technology_376/88a2348abe17af77004e5aa0fea6044e",
          "originalWidth": 1000,
          "originalHeight": 623,
          "caption": "J&J's Pennsylvania expansion falls in line with the wider industry trend towards onshoring drug manufacturing to the US. Credit: Skorzewiak/ShutterStock.com.",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/xhSGSFHrgmGMG5le43kxow--~B/aD02MjM7dz0xMDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/pharmaceutical_technology_376/88a2348abe17af77004e5aa0fea6044e.cf.webp",
              "width": 1000,
              "height": 623,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/6Oz2h4xghDpqu0JklEVAhw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/pharmaceutical_technology_376/88a2348abe17af77004e5aa0fea6044e.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Pharmaceutical Technology",
          "url": "https://www.globaldata.com/"
        },
        "canonicalUrl": {
          "url": "https://www.pharmaceutical-technology.com/news/johnson-johnson-1bn-cell-therapy-manufacturing-site-pennsylvania/",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/j-j-build-1bn-us-120212877.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-19T15:15:00+00:00",
    "headline": "Pfizer Targets Long-Term Oncology Growth Amid Competitive Pressure",
    "summary": "PFE's oncology sales rose 8% in 2025 as Padcev, Lorbrena and new launches offset Ibrance declines.",
    "url": "https://finance.yahoo.com/news/pfizer-targets-long-term-oncology-151500581.html",
    "source": "Zacks",
    "provider": "yfinance",
    "raw": {
      "id": "6b81201b-6cdb-3a09-8636-9264de13513e",
      "content": {
        "id": "6b81201b-6cdb-3a09-8636-9264de13513e",
        "contentType": "STORY",
        "title": "Pfizer Targets Long-Term Oncology Growth Amid Competitive Pressure",
        "description": "",
        "summary": "PFE's oncology sales rose 8% in 2025 as Padcev, Lorbrena and new launches offset Ibrance declines.",
        "pubDate": "2026-02-19T15:15:00Z",
        "displayTime": "2026-02-19T15:15:00Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/zacks.com/59b208c03ab625710a229f805a232093",
          "originalWidth": 635,
          "originalHeight": 400,
          "caption": "",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/w5T7o1LHfvUowVKdWOi4Rg--~B/aD00MDA7dz02MzU7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59b208c03ab625710a229f805a232093.cf.webp",
              "width": 635,
              "height": 400,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/3L0ANckA9Qf5lXTiNAgdWw--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/zacks.com/59b208c03ab625710a229f805a232093.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Zacks",
          "url": "http://www.zacks.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-targets-long-term-oncology-151500581.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/pfizer-targets-long-term-oncology-151500581.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "PFE"
            },
            {
              "symbol": "AZN"
            },
            {
              "symbol": "MRK"
            },
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  },
  {
    "ts": "2026-02-19T19:41:30+00:00",
    "headline": "Johnson & Johnson explores $20 billion sale of an orthopedics unit, Bloomberg News reports",
    "summary": "Feb 19 (Reuters) - Johnson & Johnson is preparing a potential sale of the orthopedics unit that it has been planning to separate, with big buyout firms already circling, Bloomberg News reported on",
    "url": "https://finance.yahoo.com/news/johnson-johnson-explores-20-billion-194130332.html",
    "source": "Reuters",
    "provider": "yfinance",
    "raw": {
      "id": "75494915-7692-33aa-90a0-12b9ad535b9d",
      "content": {
        "id": "75494915-7692-33aa-90a0-12b9ad535b9d",
        "contentType": "STORY",
        "title": "Johnson & Johnson explores $20 billion sale of an orthopedics unit, Bloomberg News reports",
        "description": "",
        "summary": "Feb 19 (Reuters) - Johnson & Johnson is preparing a potential sale of the orthopedics unit that it has been planning to separate, with big buyout firms already circling, Bloomberg News reported on",
        "pubDate": "2026-02-19T19:41:30Z",
        "displayTime": "2026-02-19T19:41:30Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/reuters.com/b79e669fca67bd6c0053cd4b0b22e872",
          "originalWidth": 800,
          "originalHeight": 534,
          "caption": "FILE PHOTO: A Johnson & Johnson banner is displayed on the front of the New York Stock Exchange (NYSE) in New York City, in New York City, U.S., December 5, 2023.  REUTERS/Brendan McDermid/File Photo",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/Yf_TaZ9BDBcKAT4tF0Mdeg--~B/aD01MzQ7dz04MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/b79e669fca67bd6c0053cd4b0b22e872.cf.webp",
              "width": 800,
              "height": 534,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/C0U47APrhlqNbWby_gbA.A--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/reuters.com/b79e669fca67bd6c0053cd4b0b22e872.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "Reuters",
          "url": "https://www.reuters.com/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-explores-20-billion-194130332.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/johnson-johnson-explores-20-billion-194130332.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "JNJ"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]